121 results
8-K
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
27 Dec 23
Completion of Acquisition or Disposition of Assets
8:25pm
. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions
424B3
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Nov 23
Prospectus supplement
9:15am
testing and other requirements.
AMTI cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation … will undertake or successfully complete any transactions of the nature described above, any transactions that AMTI does complete may be subject
S-4/A
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
requirements.
AMTI cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action … or successfully complete any transactions of the nature described above, any transactions that AMTI does complete may be subject to the foregoing or other risks
S-4
o6p62l5mv3gbhuynd3tl
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
425
EX-2.1
hcq79esxbm q8
21 Sep 23
Business combination disclosure
4:28pm
8-K
EX-2.1
sb81v81a sh
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
8-K
EX-10.2
dxtsf0jpm
4 May 23
Unregistered Sales of Equity Securities
3:42pm
8-K
EX-10.2
eqyda76lld
2 Mar 22
Departure of Directors or Certain Officers
4:30pm